Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Income from Continuing Operations (2016 - 2025)

Milestone Scientific's Income from Continuing Operations history spans 16 years, with the latest figure at 1153959.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 21.03% year-over-year to 1153959.0; the TTM value through Sep 2025 reached 6667190.0, down 43.85%, while the annual FY2024 figure was 4713597.0, 32.48% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 1153959.0 at Milestone Scientific, up from 1483110.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 223638.0 in Q2 2024 and bottomed at 2881329.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 1919225.0 (2022), against an average of 1695688.74.
  • The largest annual shift saw Income from Continuing Operations skyrocketed 110.03% in 2024 before it plummeted 763.17% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 1545398.0 in 2021, then fell by 28.56% to 1986829.0 in 2022, then grew by 1.52% to 1956683.0 in 2023, then fell by 4.03% to 2035535.0 in 2024, then surged by 43.31% to 1153959.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Income from Continuing Operations are 1153959.0 (Q3 2025), 1483110.0 (Q2 2025), and 1994586.0 (Q1 2025).